George Robinson is the founding partner of Oxford Investment Consultants, a firm advising on investments in spinout companies from Oxford and other UK universities. He has spoken about his own journey from investing in listed equities in Asia to championing early-stage technology ventures in the UK, and the qualities he looks for in founding teams.

Since its founding in 2015, the firm has invested over £70 million in 35 companies. He was an early backer and former board member of companies including Adaptive Immune Therapeutics and Immunocore. An Honorary Fellow of Keble College, Oxford, he holds a B.A. in Engineering Science.